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Reply to the Editor:
We thank Drs Khandani and Detterbeck for
their insightful comments on our article. Its
main conclusion was that standard uptake
values (SUVs) obtained from positron emis-
sion tomographic (PET) imaging were not
useful for staging lung cancers smaller than
2 cm. We note that there was no disagree-
ment with that conclusion, but rather the
suggestion that visual inspection by experi-
enced readers is now the accepted standard.
A listing of some of the technical reasons
why SUVs can be misleading is then given.
We agree that several recent articles
have suggested that an expert reading may
be equivalent to or better than a single cutoff
for SUV. However, this is by no means a
generally accepted standard. In fact, clini-
cians overwhelmingly continue to use the
maximum SUV for differentiating benign
from malignant lesions. This clinical prac-
tice is influenced by early PET reports,1 in
which a remarkably high accuracy of SUV
was reported for differentiating benign
from malignant nodules.
The problems outlined by Drs Khandani
and Detterbeck regarding the limitations of
the maximum SUV also affect the capabil-
ity of experienced clinicians in making
evaluations. Ultimately, anything that lim-
its the ability to make quantitative assess-
ments will also affect semiquantitative or
nonquantitative assessments as well. The
latest efforts in PET imaging include add-
ing some form of gating to improve quan-
titative assessments, and likely there will
again be discussion of whether this will
become the new accepted standard. For
now, the maximum SUV continues to be
reported and to guide clinical practice. We
look forward to improvements in PET tech-
nology and remain hopeful that the utility
of PET for small lesions will improve;
however, there are some fundamental lim-
itations that we believe will continue to be
problematic in the foreseeable future.
Jeffrey L. Port, MD
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Pulmonary lobectomy for cancer in
patients with chronic obstructive
pulmonary disease
To the Editor:
We have read with interest the report from
Baldi and colleagues1 reporting their expe-
rience with pulmonary lobectomy for lung
cancer in patients with chronic obstructive
pulmonary disease (COPD).1 On the basis
of their retrospective evaluation of 137 pa-
tients, they concluded that patients with
mild-to-severe COPD could have a better
late preservation of pulmonary function af-
ter lobectomy than healthy patients. As dis-
cussed in a very precise way by the authors,
this fact is related to a general improve-
ment of the airway caliber and elastic recoil
that could be, in its turn, related to relief of
hyperinflation, chest wall mechanics, or
both, even if in the nonemphysematous
lung. In addition, resection of dead space
could have its role.
We would like to briefly comment on
these figures, trying to relate them to the
possible role a pulmonary rehabilitation
(PR) program might have in this kind of
surgical population, and kindly ask for the
authors to disclose their point of view ac-
cording to their experience.
Today there is body of evidence regard-
ing the efficacy of PR in the comprehensive
management of patients with respiratory
disease, and PR programs are practiced
worldwide.2 Positive results in terms of
improvement in dyspnea, exercise capac-
ity, and quality of life are recognized in
chronic obstructive and nonobstructive pul-
monary disease, including COPD, cystic
fibrosis, and restrictive thoracic disease.3,4
Our group has a timely established in-
terest in the issue of PR applied to patients
who have undergone (or are candidates for)
resection for lung cancer, and we have re-
ported evidence that patients who under-
went PR after pulmonary resection demon-
strated a better improvement than those
who, at discharge from the surgical unit,
did not attend any postoperative rehabilita-
tion protocol. In fact, we have reported that
an early postoperative rehabilitative inter-
vention prevents deterioration and speeds
up recovery of function, with direct effects
on ventilatory, gas exchange, and hemody-
namic parameters (work of breathing, lung
compliance, alveolar-arterial difference,
maximum oxygen consumption, arterial
oxygen tension, heart rate, arterial lactate
concentration, cardiac index, and pulmo-
nary artery pressure) and little or no signif-
icant effect on static and dynamic lung
volumes, according to previously outlined
experiences.5 Further analysis (data sub-
mitted for publication) of our experience
supports this evidence. Because it appears
that only patients with mild-to-severe
COPD obtain an improvement in terms of
lung volumes (related to the preoperative
COPD index also)1 from the removal of
lung parenchyma associated with resection
for cancer, we would like the authors to
comment on the fact that a postoperative
rehabilitation program adopted in these pa-
tients could improve ventilatory, hemody-
namic, and gas exchange parameters con-
curring to a better clinical outcome and
quality of life status.
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